Ann: HepaFat-AI Receives TGA Approval, page-22

How many small cap stocks are cashflow positive quarter on quarter. While these are not big margins at present, a larger snapshot shows a growing revenue stream with new products being added and the exploration into AI development with the HepaFat-AI now FDA and TGA approved - time is needed to allow sales and generate uptake.

This is my most comfortable long term hold.

While I agree with others the swings in the share price may be frustrating and allow for traders - it is all part of investing - growing the business is my main concern and that is what i am seeing.